Contact us Demo our platform

Case Study

Metabolomics for Evaluating the Role of Taurine in Aging

This research study reveals that taurine is a promising metabolic target for increasing healthy life span in humans.

The Metabolon Global Discovery Panel and targeted metabolomics showed that in humans, low taurine levels are associated with multiple age-related diseases and that exercise training can increase taurine levels.

Talk With An Expert About Your Project

The Metabolon Global Discovery Panel and targeted metabolomics showed that in humans, low taurine levels are associated with multiple age-related diseases and that exercise training can increase taurine levels.

Talk With An Expert About Your Project
Metabolomics for Evaluating the Role of Taurine in Aging

The Challenge: Exploring Taurine’s Impact on Aging

Aging is a biological process that leads to increased vulnerability to diseases and, ultimately, death. It is a significant risk factor for developing type 2 diabetes, cardiovascular diseases, and cancer. Ensuring that the elderly remain healthy is crucial to enhance their quality of life and reduce the societal costs associated with aging. Therefore, more efforts have been placed on identifying compounds that may increase the healthy lifespan. Taurine is a naturally occurring semi-essential amino acid found in various body tissues, particularly in high concentrations in the brain, heart, and muscle.1 Due to the decrease in taurine levels as people age and its established impact on health, this study aimed to investigate whether taurine deficiency contributes to the aging process and influences longevity.2

The Metabolon Insight: Metabolon’s Approach Explores a Link Between Taurine Metabolites and Aging

This research group used the Global Discovery Panel to profile human blood samples. Metabolon provided the most extensive solution to determine whether taurine and taurine-related metabolites are linked to age-associated diseases. Metabolon also helped this group perform targeted metabolomics of taurine pathway metabolites in the serum of a human exercise cohort.

The Solution: Taurine Supplementation is Linked to Human Health Variables that Influence Aging

This study demonstrated a decline in serum taurine levels in aged mice, monkeys, and humans. This research team also showed that taurine supplementation increased the health span and life span of mice and the health span of monkeys and worms. Mechanistically, taurine supplementation decreased DNA damage, protected against telomerase deficiency, and attenuated inflammation in mouse and zebrafish models.

Next, this study also aimed to determine whether taurine is associated with human health variables. To do this, they performed an association analysis of circulating taurine levels with clinical risk factors. The Global Discovery Panel revealed that lower levels of taurine pathway metabolites (taurine, hypotaurine, and N-acetyltaurine) were associated with type 2 diabetes, obesity, and higher waist-to-hip ratio in humans. Conversely, targeted metabolomics showed that exercise increased the concentrations of taurine metabolites in blood.

The Outcome: Metabolomics Reveals a Promising Target to Combat Aging

Untargeted metabolomics demonstrated that in humans, lower levels of taurine pathway metabolites were associated with multiple age-related diseases, such as obesity and diabetes. Targeted metabolomics showed that taurine levels increase after exercise training in humans. These clinically relevant findings indicate that taurine supplementation may be a promising antiaging strategy. In the future, human trials must be carried out to examine whether taurine supplementation increases healthy life span in humans.

References

1. Wu G. Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health. Amino Acids. Mar 2020;52(3):329-360. doi:10.1007/s00726-020-02823-6

2. Singh P, Gollapalli K, Mangiola S, et al. Taurine deficiency as a driver of aging. Science. Jun 09 2023;380(6649):eabn9257. doi:10.1126/science.abn9257

Related Case Studies

See All Case Studies
✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.